The inhibition of tacrolimus on rosuvastatin uptake in human SCH, including its trans-inhibition and long-lasting inhibition characteristics, is worth further investigation to elucidate the clinically relevant potential of OATP-mediated DDIs via tacrolimus. The gene discussed is SLCO1A2; the disease is spindle cell hemangioma.